Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

2020245 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 396, Issue 10244, pp. 110-120

Field-Weighted Citation Impact: 16.30